Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Opus Genetics (IRD) Profit After Tax (2020 - 2026)

Opus Genetics has reported Profit After Tax over the past 12 years, most recently at -$65.5 million for Q1 2026.

  • Quarterly Profit After Tax fell 699.79% to -$65.5 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$106.9 million through Mar 2026, down 82.42% year-over-year, with the annual reading at -$49.6 million for FY2025, 13.8% up from the prior year.
  • Profit After Tax was -$65.5 million for Q1 2026 at Opus Genetics, down from -$16.5 million in the prior quarter.
  • Over five years, Profit After Tax peaked at $33.9 million in Q4 2022 and troughed at -$65.5 million in Q1 2026.
  • The 5-year median for Profit After Tax is -$7.1 million (2024), against an average of -$9.7 million.
  • Year-over-year, Profit After Tax surged 637.64% in 2022 and then crashed 699.79% in 2026.
  • A 5-year view of Profit After Tax shows it stood at $33.9 million in 2022, then plummeted by 114.13% to -$4.8 million in 2023, then tumbled by 632.74% to -$35.1 million in 2024, then skyrocketed by 52.97% to -$16.5 million in 2025, then tumbled by 296.63% to -$65.5 million in 2026.
  • Per Business Quant, the three most recent readings for IRD's Profit After Tax are -$65.5 million (Q1 2026), -$16.5 million (Q4 2025), and -$17.5 million (Q3 2025).